Relation of Baseline Hemoglobin Level to In-Hospital Outcomes in Patients Who Undergo Percutaneous Coronary Intervention (from a Japanese Multicenter Registry).

[1]  J. Spertus,et al.  Preinfarct Health Status and the Use of Early Invasive Versus Ischemia-Guided Management in Non-ST-Elevation Acute Coronary Syndrome. , 2017, The American journal of cardiology.

[2]  H. Miyata,et al.  Outcomes After Percutaneous Coronary Intervention of Acute Coronary Syndrome Complicated With Cardiopulmonary Arrest (from a Japanese Multicenter Registry). , 2017, The American journal of cardiology.

[3]  A. Vora,et al.  Blood Transfusion and the Risk of Acute Kidney Injury Among Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention , 2016, Circulation. Cardiovascular interventions.

[4]  A. Zaman,et al.  Meta-Analysis of the Prognostic Impact of Anemia in Patients Undergoing Percutaneous Coronary Intervention. , 2016, The American journal of cardiology.

[5]  M. Qiu,et al.  Impact of anemia on long-term ischemic events and bleeding events in patients undergoing percutaneous coronary intervention: a system review and meta-analysis. , 2015, Journal of thoracic disease.

[6]  H. Miyata,et al.  Development and validation of a pre-percutaneous coronary intervention risk model of contrast-induced acute kidney injury with an integer scoring system. , 2015, The American journal of cardiology.

[7]  H. Miyata,et al.  Impact of Body Mass Index on In-Hospital Complications in Patients Undergoing Percutaneous Coronary Intervention in a Japanese Real-World Multicenter Registry , 2015, PloS one.

[8]  C. Kwok,et al.  Blood transfusion after percutaneous coronary intervention and risk of subsequent adverse outcomes: a systematic review and meta-analysis. , 2015, JACC. Cardiovascular interventions.

[9]  H. Miyata,et al.  Location of the culprit coronary lesion and its association with delay in door-to-balloon time (from a multicenter registry of primary percutaneous coronary intervention). , 2015, The American journal of cardiology.

[10]  L. Räber,et al.  Additive Effect of Anemia and Renal Impairment on Long-Term Outcome after Percutaneous Coronary Intervention , 2014, PloS one.

[11]  Samin K. Sharma,et al.  Impact of major bleeding on long-term mortality in anemic versus nonanemic patients undergoing percutaneous coronary intervention using bivalirudin. , 2014, The American journal of cardiology.

[12]  Ajay K. Jain,et al.  Prognostic impact of anaemia on patients with ST-elevation myocardial infarction treated by primary PCI , 2014, Coronary artery disease.

[13]  S. Berliner,et al.  Hemoglobin nonrecovery following acute myocardial infarction is a biomarker of poor outcome: a retrospective database study. , 2013, International journal of cardiology.

[14]  Takeshi Kimura,et al.  Prognostic implications of anemia with or without chronic kidney disease in patients undergoing elective percutaneous coronary intervention. , 2013, International journal of cardiology.

[15]  K. Seung,et al.  Improved anemia is associated with favorable long-term clinical outcomes in patients undergoing PCI , 2012, Coronary artery disease.

[16]  M. Zwahlen,et al.  The Impact of Anemia on Long-Term Clinical Outcome in Patients Undergoing Revascularization With the Unrestricted Use of Drug-Eluting Stents , 2012, Circulation. Cardiovascular interventions.

[17]  K. Alexander,et al.  Recovery from hospital-acquired anemia after acute myocardial infarction and effect on outcomes. , 2011, The American journal of cardiology.

[18]  Keith R. Abrams,et al.  Threshold Haemoglobin Levels and the Prognosis of Stable Coronary Disease: Two New Cohorts and a Systematic Review and Meta-Analysis , 2011, PLoS medicine.

[19]  E. Abu-Assi,et al.  Evaluating the Performance of the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines (CRUSADE) Bleeding Score in a Contemporary Spanish Cohort of Patients With Non–ST-Segment Elevation Acute Myocardial Infarction , 2010, Circulation.

[20]  G. Stone,et al.  Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial). , 2010, The American journal of cardiology.

[21]  Eric Fretz,et al.  Body mass index, periprocedural bleeding, and outcome following percutaneous coronary intervention (from the British Columbia Cardiac Registry). , 2009, The American journal of cardiology.

[22]  Deepak L. Bhatt,et al.  The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic disease. , 2008, European heart journal.

[23]  R. Giugliano,et al.  Association of Hemoglobin Levels With Clinical Outcomes in Acute Coronary Syndromes , 2005, Circulation.

[24]  H. Miyata,et al.  Incidence and predictors of bleeding complications after percutaneous coronary intervention. , 2017, Journal of cardiology.

[25]  T. Murohara,et al.  Impact of Admission Anemia on Coronary Microcirculation and Clinical Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. , 2015, International heart journal.

[26]  S. Matoba,et al.  Prognostic impact of chronic kidney disease and anemia at admission on in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction. , 2014, International heart journal.

[27]  S. Yusuf,et al.  Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes. , 2010, European heart journal.